Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Rayno Life Science Stocks Rally: Green Screen... IBB UP 2.5%

|Includes:Achillion Pharmaceuticals, Inc. (ACHN), EXAS

Rayno Biopharmaceutical and Diagnostic Stocks In BIG Rally

Biggest movers in Biopharma-Large Caps Still Rule Near All Time Highs

ALXN, AMGN, BIIB, GILD, REGN

Mid and Small Cap movers: AMRI, CBST, IMGN, SGEN

Achillion Pharmaceuticals (ACHN $3.54) our only loser is looking better. We added more at $3.40.

Diagnostic Stocks Pick Up Steam Up Over 2%

EXAS up 8% anticipating colorectal screening test approval.

CPHD, GHDX, NSPH, QDEL, QGEN

Investment posture: maintain 15% cash, stay with Rayno Portfolio stocks, avoid high fliers and small cap speculative stocks. Using ETFs as a marker the sector is at the low end of a rising channel up 17% YTD.

Chart foriShares Nasdaq Biotechnology (NASDAQ:<a href='http://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a>)

Disclosure: I am long ACHN.

Additional disclosure: I am long Fidelity Select Biotechnology Fund (MUTF:FBIOX) and short selective mid cap stocks as a hedge.

Stocks: ACHN, EXAS